tirzepatide injection pen 40mg Kit Retatrutide 40mg (R&D Only) -

The phentermine and tirzepatide combination guide and the AOD-9604 with tirzepatide guide cover two of the more commonly discussed combinations

Scott Butsch, director of obesity medicine at Cleveland Clinics Bariatric and Metabolic Institute

Trial Status Note: Information presented below is based on published data and publicly available trial registries

You can also speak to your doctor

Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for type 2 diabetes management (Mounjaro) and chronic weight management in adults with obesity or overweight with weight-related conditions (Zepbound)

This common question reflects confusion about proper storage for this dual GIP/GLP-1 receptor agonist used in type 2 diabetes and chronic weight management